Correlation Between Alphatec Holdings and Neuropace

Can any of the company-specific risk be diversified away by investing in both Alphatec Holdings and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphatec Holdings and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alphatec Holdings and Neuropace, you can compare the effects of market volatilities on Alphatec Holdings and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphatec Holdings with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphatec Holdings and Neuropace.

Diversification Opportunities for Alphatec Holdings and Neuropace

0.85

Correlation Coefficient

Alphatec Holdings  Neuropace

Very poor diversification

The 3 months correlation between Alphatec and Neuropace is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Alphatec Holdings and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Alphatec Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphatec Holdings are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Alphatec Holdings i.e., Alphatec Holdings and Neuropace go up and down completely randomly.

Pair Corralation between Alphatec Holdings and Neuropace

Given the investment horizon of 90 days Alphatec Holdings is expected to generate 19.71 times less return on investment than Neuropace. But when comparing it to its historical volatility, Alphatec Holdings is 1.46 times less risky than Neuropace. It trades about 0.01 of its potential returns per unit of risk. Neuropace is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  163.00  in Neuropace on September 28, 2024 and sell it today you would earn a total of  904.00  from holding Neuropace or generate 554.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Alphatec Holdings  vs.  Neuropace

Alphatec Holdings

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Alphatec Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Alphatec Holdings exhibited solid returns over the last few months and may actually be approaching a breakup point.

Neuropace

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Alphatec Holdings and Neuropace

The main advantage of trading using opposite Alphatec Holdings and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphatec Holdings position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind Alphatec Holdings and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.